BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7109324)

  • 1. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
    Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
    Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of adrenal imaging with 123I-labeled-6 beta-iodomethyl-19-norcholesterol (author's transl)].
    Shishido F; Tateno Y; Ido T; Irie T; Suzuki K; Fukushi K; Iwata R; Kojima M; Maeda M; Ito T; Ogawa H
    Radioisotopes; 1980 Nov; 29(11):526-32. PubMed ID: 7244299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)].
    Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S
    Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223
    [No Abstract]   [Full Text] [Related]  

  • 4. [Scintigraphic exploration of the adrenal glands using I-131-6 beta iodomethyl-19-norcholesterol. A practical guide].
    Kraimps JL; Bardet S; Nocaudie-Calzada M; Tabarin A; Wémeau JL
    Ann Chir; 1999; 53(3):255-60. PubMed ID: 10339872
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia.
    Gordon L; Mayfield RK; Levine JH; Lopes-Virella MF; Sagel J; Buse MG
    J Nucl Med; 1980 Jan; 21(1):49-51. PubMed ID: 7356739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of a new adrenal scanning agent, 6-methyl-75Se-selenomethyl-19-norcholest-5 (10)-en-3 beta-ol (75Se-Scintadren) and 6 beta-iodomethyl-19-norcholest-5 (10)-en-3 beta-ol (131I-Adosterol) (author's transl)].
    Seto H; Futatsuya R; Mori H; Koizumi K; Hisada K
    Kaku Igaku; 1979 Apr; 16(2):183-9. PubMed ID: 470240
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent.
    Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC
    Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal scintigraphy using 123I labeled 6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-123I).
    Kamoi I; Oshiumi Y; Tateno Y; Shishido F; Ido T; Suzuki K; Irie T; Fukushi K; Nakayama C; Matsuura K; Itoh T; Ogawa H; Maeda M; Kojima M
    Kaku Igaku; 1980 May; 17(4):389-93. PubMed ID: 7401398
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
    Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
    J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of percent uptake in the adrenal glands with 131I-adosterol (author's transl)].
    Fujita T; Fukunaga M; Mukai T; Yamamoto I; TorizukaD okoh S; Ishii Y; Morita R; Kawamura K; Kawamura J
    Kaku Igaku; 1980 Mar; 17(2):219-27. PubMed ID: 7382187
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging.
    Kazerooni EA; Sisson JC; Shapiro B; Gross MD; Driedger A; Hurwitz GA; Mattar AG; Petry NA
    J Nucl Med; 1990 Apr; 31(4):526-34. PubMed ID: 2324830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of adrenal 131-I-19-iodocholesterol scintigraphy in the etiological diagnosis of primary hyperaldosteronism].
    Rodat O; Charbonnel B; Lucas B; Weber M; Donet P; Mitard D; Tellier JL
    Rev Med Interne; 1982; 3(3):257-61. PubMed ID: 7178715
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advances in adrenal scintigraphy. Selected problems concerning the technique of investigations and interpretation of scintigrams (author's transl)].
    Jakubowski W; Graban W; Feltynowski T
    Pol Przegl Radiol Med Nukl; 1979; 43(5):307-9. PubMed ID: 542406
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
    Gordon L; Levine JH; Mayfield RK; Buse MG
    J Nucl Med; 1979 Aug; 20(8):897-8. PubMed ID: 541739
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic evaluation of the adrenal scanning using 131I-adosterol (author's transl)].
    Sugawara S; Nakamura M; Sawai Y; Fukuchi S
    Kaku Igaku; 1978 Dec; 15(8):1155-63. PubMed ID: 748650
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical use of 131I-19-iodocholesterol adrenal scintiphotography.
    Chin Med J (Engl); 1979 Apr; 92(4):233-6. PubMed ID: 108054
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adrenal scanning using 19-iodocholesterol-I131].
    Slavnov VN; Valueva GV; Luchitskiĭ EV; Markov VV; Iakovlev AA
    Vrach Delo; 1979 Jul; (7):32-5. PubMed ID: 473741
    [No Abstract]   [Full Text] [Related]  

  • 18. 131I-6-iodocholesterol, an agent for imaging the adrenal gland.
    Jixiao M; Ruisen Z
    Chin Med J (Engl); 1979 Apr; 92(4):237-46. PubMed ID: 108055
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation dosimetry of adrenal imaging agents 19-iodocholesterol and 6-iodomethylnorcholesterol.
    Brookeman VA
    Int J Appl Radiat Isot; 1978 May; 29(4-5):277-9. PubMed ID: 689751
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adrenal scintigraphy with 131I-6beta-iodomethyl-19-norcholesterol: good practice guideline].
    Bardet S; Nocaudie-Calzada M; Kraimps JL; Tabarin A; Wémeau JL
    Ann Endocrinol (Paris); 1998 Nov; 59(4):344-53. PubMed ID: 9864556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.